R. Bettahar

Androgen deprivation therapy and radiotherapy in intermediate-risk prostate cancer: A randomised phase III trial.

É. Vigneault, N. Carrier, L. Souhami, 2020, European journal of cancer.

The use of a specific hypofractionated radiation therapy regimen versus classical fractionation in the treatment of breast cancer: a randomized study of 230 patients.

F. Baillet, M. Housset, G. Boisserie, 1990, International journal of radiation oncology, biology, physics.

Phase 3 Study of Hypofractionated, Dose Escalation Radiation Therapy for High-Risk Adenocarcinoma of the Prostate

M. Yassa, M. Barkati, André-Guy Martin, 2017 .

Duration of Androgen Deprivation Therapy in High-risk Prostate Cancer: A Randomized Phase III Trial.

J. Bahary, N. Carrier, L. Souhami, 2018, European urology.

OPTIMIZING TREATMENT IN INTERMEDIATE RISK PROSTATE CANCER: SECONDARY ANALYSIS OF A RANDOMIZED PHASE III TRIAL.

É. Vigneault, N. Carrier, L. Souhami, 2021, International journal of radiation oncology, biology, physics.

The Clinical Significance of Bone Mineral Density Changes Following Long-Term Androgen Deprivation Therapy in Localized Prostate Cancer Patients

M. Yassa, M. Barkati, André-Guy Martin, 2021, The Journal of urology.

Duration of androgen deprivation therapy in high risk prostate cancer: Final results of a randomized phase III trial.

J. Bahary, N. Carrier, L. Souhami, 2017 .